ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

Sumitomo Pharma America, Inc. · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
par
perennial allergic rhinitis, par, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1010974
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.